Larson Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.3K	Buy	661 +98	+17%	+$5.71K	﹤0.01%	1514
2025 Q4	$33.5K	Sell	563 -420	-43%	-$22.9K	﹤0.01%	1434
2025 Q3	$53.2K	Sell	983 -416	-30%	-$23.8K	﹤0.01%	1133
2025 Q2	$76.9K	Sell	1,399 -867	-38%	-$51.1K	﹤0.01%	927
2025 Q1	$160K	Buy	2,266 +1,898	+516%	+$128K	0.01%	671
2024 Q4	$24.2K	Buy	368 +190	+107%	+$12.7K	﹤0.01%	1146
2024 Q3	$12.5K	Buy	178 +1	+0.6%	+$84	﹤0.01%	1385
2024 Q2	$14.6K	Hold	177	–	–	﹤0.01%	1151
2024 Q1	$15.5K	Hold	177	–	–	﹤0.01%	945
2023 Q4	$17.1K	Sell	177 -13	-7%	-$1.15K	﹤0.01%	890
2023 Q3	$16.8K	Buy	190 +13	+7%	+$1.16K	﹤0.01%	864
2023 Q2	$15.3K	Hold	177	–	–	﹤0.01%	812
2023 Q1	$17.2K	Buy	177 +14	+9%	+$1.45K	﹤0.01%	781
2022 Q4	$16.9K	Hold	163	–	–	﹤0.01%	733
2022 Q3	$14K	Hold	163	–	–	﹤0.01%	701
2022 Q2	$14K	Hold	163	–	–	﹤0.01%	622
2022 Q1	$13K	Hold	163	–	–	﹤0.01%	590
2021 Q4	$14K	Buy	+163	New	+$13.4K	﹤0.01%	605